In simple terms, Terns Pharmaceuticals, Inc. has 61.794 M shares that people are buying and selling right now.
Return on Investments
The company's asset efficiency, represented by a robust -0.313% return, is a testament to Terns Pharmaceuticals, Inc.'s adeptness in optimizing resource deployment. Terns Pharmaceuticals, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.310%. Furthermore, the proficiency of Terns Pharmaceuticals, Inc. in capital utilization is underscored by a remarkable -0.367% return on capital employed.
Stock Prices
Terns Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $5.26, while its low point bottomed out at $4.2507. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Terns Pharmaceuticals, Inc.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
